Cardiac Electrophysiology
Long QT Syndrome
A practical framework for confirming congenital long QT syndrome, excluding acquired QT prolongation, identifying concealed disease, initiating genotype-informed arrhythmic risk reduction, and escalating to sympathetic denervation or defibrillator-based protection when breakthrough events persist.
Immediate decisions
Identify torsades risk and reversible QT prolongation first
Treat unstable ventricular arrhythmia and correct acquired contributors before assigning an inherited diagnosis.
In a patient with syncope, polymorphic ventricular tachycardia, aborted cardiac arrest, or marked QT prolongation, obtain a 12-lead ECG and immediately review all prescribed, over-the-counter, and administered drugs for QT-prolonging exposure. Acquired long QT may result from medications, electrolyte abnormalities, eating disorders, coronary artery disease, and bradyarrhythmia; these conditions must be addressed before interpreting QTc as evidence of congenital LQTS. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
Document the presenting rhythm whenever possible. Torsades de pointes is a diagnostic component of the Schwartz score, but do not double-count torsades and syncope in that score because they are mutually exclusive criteria. ScienceDirectScienceDirectQTc Interval - an overview A history of syncope during stress carries more diagnostic weight than syncope without stress, supporting an adrenergically mediated inherited arrhythmia phenotype. ScienceDirectScienceDirectQTc Interval - an overview
Patients with known or suspected congenital LQTS warrant particular caution with ondansetron and other QT-prolonging agents because congenital LQTS is a recognized substrate for drug-associated torsades. annemergmedannemergmedOndansetron and the Risk of Cardiac Arrhythmias If QT-prolonging therapy cannot be avoided, reassess the ECG and correct modifiable acquired factors before exposure.
Obtain a medication and substance exposure history, including recently administered antiemetics and other QT-prolonging therapies. Nature+1NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryannemergmedOndansetron and the Risk of Cardiac Arrhythmias
Measure and correct electrolyte abnormalities and assess for clinically relevant bradyarrhythmia before diagnosing congenital LQTS. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
Elicit exertional or emotional-stress syncope, documented torsades, congenital deafness, definite LQTS in relatives, and unexplained sudden death before age 30 years in immediate relatives. ScienceDirectScienceDirectQTc Interval - an overview
| Finding | Interpretation | Next action |
|---|---|---|
| QT prolongation with QT-prolonging medication exposure | Acquired long QT is possible. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery | Stop or substitute the culprit drug when feasible; reassess QTc after reversible factors are addressed. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery |
| QT prolongation with electrolyte abnormality, bradyarrhythmia, eating disorder, or coronary disease | These are recognized acquired contributors. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery | Correct the contributor and repeat ECG assessment before concluding congenital LQTS. NatureNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery |
| Persistent QTc prolongation without acquired cause plus stress syncope, torsades, or suggestive family history | Clinical probability of congenital LQTS rises. ScienceDirectScienceDirectQTc Interval - an overview | Calculate Schwartz score, obtain inherited-arrhythmia evaluation, and consider genetic testing. ScienceDirect+1ScienceDirectQTc Interval - an overviewScienceDirectRR Interval - an overview |
| Normal resting QTc but convincing personal or family history | Concealed LQTS remains possible. ScienceDirectScienceDirectRR Interval - an overview | Perform exercise testing with QT evaluation during prolonged recovery and consider genetic testing. ScienceDirectScienceDirectRR Interval - an overview |
Diagnostic workup
Confirm phenotype with QTc, Schwartz scoring, and targeted provocation
Use serial, carefully measured ECG data rather than a single automated QTc result.
Obtain a high-quality resting 12-lead ECG after reversible acquired causes have been addressed. Bazett correction is commonly used: QTc equals QT divided by the square root of the RR interval. ScienceDirect+1ScienceDirectQTc Interval - an overviewScienceDirectLong QT Syndrome and Perioperative Torsades de Pointes In pediatric diagnostic assessment, measure QT across multiple leads and average RR intervals over several beats; computer QT measurement is unreliable for this purpose. ScienceDirectScienceDirectRR Interval - an overview
Apply the Schwartz score only when ECG findings are not explained by medications or disorders that alter repolarization. QTc of at least 480 ms scores 3 points; QTc 460 to 470 ms scores 2 points; and QTc 450 ms scores 1 point. Torsades de pointes scores 2 points, T-wave alternans and notched T waves in three leads each score 1 point, and resting heart rate below the second percentile for age scores 0.5 point. ScienceDirectScienceDirectQTc Interval - an overview
A Schwartz score of 4 or greater indicates high probability, 2 to 3 intermediate probability, and 1 or less low probability of LQTS. ScienceDirectScienceDirectQTc Interval - an overview Clinical history modifies the result: stress-related syncope scores 2 points, nonstress syncope 1 point, congenital deafness 0.5 point, a family member with definite LQTS 1 point, and unexplained sudden death before age 30 years in an immediate family member 0.5 point. ScienceDirectScienceDirectQTc Interval - an overview
Do not dismiss a patient with a normal baseline QTc when the phenotype is compelling. Approximately 25% of patients with a pathogenic LQTS variant may have normal QTc intervals. ScienceDirectScienceDirectRR Interval - an overview Exercise testing or epinephrine infusion can support assessment of concealed LQTS, but neither provocative approach has adequate sensitivity or specificity to establish the diagnosis in isolation. ScienceDirectScienceDirectRR Interval - an overview
For exercise testing, continue QT evaluation through an extended recovery period rather than relying only on the peak-exercise tracing. ScienceDirectScienceDirectRR Interval - an overview
Use provocative testing as a phenotype-enhancing test in high-suspicion, nondiagnostic cases—not as a stand-alone exclusion or confirmation strategy. ScienceDirectScienceDirectRR Interval - an overview
Refer high-probability, intermediate-probability, and phenotype-discordant cases for inherited-arrhythmia interpretation of ECG, exercise, and genetic findings. jacc+1jaccCongenital Long QT SyndromeScienceDirectRR Interval - an overview
| Domain | Criterion | Points |
|---|---|---|
| ECG | QTc ≥480 ms | 3 ScienceDirectScienceDirectQTc Interval - an overview |
| ECG | QTc 460–470 ms | 2 ScienceDirectScienceDirectQTc Interval - an overview |
| ECG | QTc 450 ms | 1 ScienceDirectScienceDirectQTc Interval - an overview |
| ECG | Torsades de pointes | 2 ScienceDirectScienceDirectQTc Interval - an overview |
| Clinical history | Syncope with stress; syncope without stress | 2; 1 ScienceDirectScienceDirectQTc Interval - an overview |
| Family history | Definite LQTS in a family member; unexplained sudden death before age 30 years in an immediate relative | 1; 0.5 ScienceDirectScienceDirectQTc Interval - an overview |
| Interpretation | Low, intermediate, and high probability | ≤1; 2–3; ≥4 ScienceDirectScienceDirectQTc Interval - an overview |
Etiologic branches
Use genotype and trigger pattern to refine counseling and treatment
Genetic results inform disease classification but do not replace clinical phenotype assessment.
Prioritize the three major autosomal-dominant phenotypes—LQT1, LQT2, and LQT3—during inherited-arrhythmia assessment. LQT1 is associated with KCNQ1, LQT2 with KCNH2, and LQT3 with SCN5A; these three subtypes account for approximately 80% to 90% of LQTS cases. jacc+1jaccCongenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery The remainder includes less common genes, while at least 30% of clinically clear LQTS can remain genotype-elusive. Nature+1NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryNatureClinical utility gene card for: Long-QT syndrome
Use the clinical trigger pattern to guide evaluation of a borderline phenotype. LQT1 commonly shows marked QTc prolongation with exercise, making exercise testing with extended recovery particularly useful when baseline ECG is nondiagnostic. ScienceDirectScienceDirectRR Interval - an overview LQT3 is linked to SCN5A and has bradycardia-triggered arrhythmia mechanisms, so review resting rate, sleep/rest events, and bradyarrhythmia as part of phenotype assignment. jaccjaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Order genetic testing in clinically probable LQTS and in selected high-suspicion concealed cases, with pre- and post-test counseling. A pathogenic variant can clarify diagnosis and permit cascade evaluation of relatives; however, a variant of uncertain significance does not independently establish disease, and a negative result does not exclude LQTS. Nature+1NatureClinical utility gene card for: Long-QT syndromeScienceDirectRR Interval - an overview Evaluate relatives of affected patients because phenotype may be absent at a single assessment despite genetic predisposition. cdn clinicaltrialscdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024
LQT1: KCNQ1; assess exercise-associated QT behavior. Nature+1NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryScienceDirectRR Interval - an overview
LQT2: KCNH2; integrate ECG phenotype, symptoms, and molecular findings rather than genotype alone. jacc+1jaccCongenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
LQT3: SCN5A; assess for bradycardia-associated arrhythmia features and consider genotype-directed therapy in an inherited-arrhythmia program. jaccjaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Genotype-negative disease remains clinically actionable when phenotype and family history support LQTS. Nature+1NatureClinical utility gene card for: Long-QT syndromeScienceDirectRR Interval - an overview
Definitive management
Reduce recurrent ventricular arrhythmia risk with beta-blockade and escalation pathways
Therapy intensity should follow prior events, treatment tolerance, and breakthrough arrhythmia burden.
Initiate beta-blocker therapy for congenital LQTS as the core preventive treatment strategy; beta-blocker efficacy has been evaluated in high-risk LQT1 and LQT2 populations and is incorporated in U.S. ventricular-arrhythmia guidance. jaccjacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society In infants and children, the paradoxical use of beta-blockers for LQTS is specifically directed at prevention of ventricular arrhythmias. neoreviews aappublicationsneoreviews aappublicationsEvaluation and Management of Common Neonatal ... Select agent and dose through electrophysiology or inherited-arrhythmia care because the cited evidence does not provide a universal dose regimen.
Define a breakthrough cardiac event as syncope, sustained ventricular arrhythmia, aborted cardiac arrest, or other clinician-adjudicated LQTS-associated event occurring despite effective pharmacotherapy. Such events should trigger confirmation of adherence, reassessment for QT-prolonging drugs and acquired contributors, review of genotype and trigger pattern, and referral for treatment intensification. AHA Journals+2AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT SyndromeNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
For LQT3, mexiletine has gene-specific evidence for reducing arrhythmic events in affected patients. jaccjaccClinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy Use this as genotype-directed management rather than empiric therapy for unclassified QT prolongation, and monitor treatment response within an inherited-arrhythmia program.
Continue avoidance of QT-prolonging medications and promptly correct acquired QT-prolonging conditions throughout follow-up. Nature+1NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryannemergmedOndansetron and the Risk of Cardiac Arrhythmias
At each follow-up, document interval syncope, palpitations, resuscitated arrest, medication adherence, resting ECG/QTc, and new drug exposures. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyNatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery
Escalate after breakthrough events rather than assuming a single syncopal episode represents beta-blocker failure without reassessing competing causes and treatment implementation. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome
When to consider ICD-based protection
The 2017 AHA/ACC/HRS ventricular-arrhythmia guideline includes specific recommendations for congenital LQTS and cites long-term ICD outcome studies in high-risk LQTS. jaccjacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Refer patients with prior aborted cardiac arrest, recurrent life-threatening arrhythmia despite medical therapy, or complex decisions regarding ICD candidacy to electrophysiology; device selection must weigh arrhythmic protection against the long-term burden of device complications and shocks. jacc+1jaccCongenital Long QT Syndromejacc2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
When to use left cardiac sympathetic denervation
Consider left cardiac sympathetic denervation (LCSD) as treatment intensification for patients with LQTS who experience breakthrough cardiac events while receiving effective beta-blocker therapy. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome LCSD is also used as adjunctive therapy when beta-blocker adverse effects limit dosing and dose reduction is needed. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome
LCSD can be performed through a minimally invasive video-assisted thoracic approach, typically removing sympathetic chain/ganglia from T4 to T1 including the lower half of the left stellate ganglion. AHA JournalsAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology Discuss expected autonomic adverse effects, including unilateral hand dryness, facial color or temperature asymmetry, and abnormal sweating. AHA JournalsAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology
Do not present LCSD monotherapy as routine first-line care; published monotherapy use has focused on selected patients unable to tolerate beta-blockers and requires individualized specialist assessment. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome
Use LCSD to reduce arrhythmic burden; it is an antifibrillatory intervention and does not eliminate the need for continued phenotype-based risk assessment. AHA Journals+1AHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and ElectrophysiologyAHA JournalsLeft Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome
Longitudinal care
Screen relatives and make activity decisions through shared risk assessment
A single normal ECG does not reliably exclude familial disease.
Construct a three-generation pedigree that specifically captures definite LQTS, unexplained sudden death before age 30 years, syncope, seizures of uncertain cause, and resuscitated cardiac arrest. The Schwartz score assigns points for definite LQTS in a family member and young unexplained sudden death in an immediate relative, making family history diagnostically consequential rather than merely descriptive. ScienceDirectScienceDirectQTc Interval - an overview
Offer clinical and genetic evaluation to relatives when a familial pathogenic variant or convincing clinical phenotype is present. Concealed inherited arrhythmia syndromes may remain undiagnosed because phenotype can be absent at the time of assessment, and LQTS may manifest around physiologic autonomic changes such as immediately after exercise. cdn clinicaltrialscdn clinicaltrials1 IRAS: 330619 Version 4 Date: 02/04/2024 Repeat phenotype assessment should be guided by age, symptoms, family genotype, and inherited-arrhythmia specialist recommendations.
Do not apply blanket sports exclusion solely from the diagnostic label. Return-to-play decisions for athletes with LQTS require individualized assessment within national and international guidance, integrating clinical events, treatment adherence, QT phenotype, genotype, sport setting, and emergency-action planning. jaccjaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death
Provide written documentation of the diagnosis or suspected diagnosis for medication reconciliation, emergency care, perioperative planning, and sports discussions. ScienceDirect+1ScienceDirectLong QT Syndrome and Perioperative Torsades de PointesannemergmedOndansetron and the Risk of Cardiac Arrhythmias
Reassess medication lists at every encounter because exposure to QT-prolonging drugs can convert a stable phenotype into acquired torsades risk. Nature+1NatureIon channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell DiscoveryannemergmedOndansetron and the Risk of Cardiac Arrhythmias
Direct family screening and athlete participation decisions to clinicians experienced in inherited arrhythmias when the phenotype is concealed, genotype results are uncertain, or prior arrhythmic events have occurred. jacc+2jaccCongenital Long QT SyndromejaccReturn-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden DeathScienceDirectRR Interval - an overview
References
- Congenital Long QT Syndrome — www.jacc.org · www.jacc.org
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society — www.jacc.org · www.jacc.org
- Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy — www.jacc.org · www.jacc.org
- Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death — www.jacc.org · www.jacc.org
- Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome | Circulation: Arrhythmia and Electrophysiology — www.ahajournals.org · www.ahajournals.org
- Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome — www.ahajournals.org · www.ahajournals.org
- Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome | Cell Discovery — www.nature.com · www.nature.com
- The long QT syndrome family of cardiac ion channelopathies — www.nature.com · www.nature.com
- Clinical utility gene card for: Long-QT syndrome — www.nature.com · www.nature.com
- Clinical utility gene card for: Long-QT Syndrome (types 1–13) — www.nature.com · www.nature.com
- Perinatal Management of Andersen–Tawil Syndrome Using a ... — obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
- QTc Interval - an overview — www.sciencedirect.com · www.sciencedirect.com
- Long QT Syndrome and Perioperative Torsades de Pointes — www.sciencedirect.com · www.sciencedirect.com
- Improving long QT syndrome diagnosis by a polynomial- ... — www.sciencedirect.com · www.sciencedirect.com
- RR Interval - an overview — www.sciencedirect.com · www.sciencedirect.com
- Long QT Syndrome : New England Journal of Medicine — journals.lww.com · journals.lww.com
- Clinical Characteristics and Genetic Background of ... — journals.lww.com · journals.lww.com
- Targeted next generation sequencing revealed a novel deletion- ... — journals.lww.com · journals.lww.com
- Heart Rate and Rhythm Disorders | Pediatrics In Review — pedsinreview.aappublications.org · pedsinreview.aappublications.org
- 1 IRAS: 330619 Version 4 Date: 02/04/2024 — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
- A Review of Long QT Syndrome: Everything a Hospitalist ... — hosppeds.aappublications.org · hosppeds.aappublications.org
- Sudden Death in the Young: Information for the Primary ... — pediatrics.aappublications.org · pediatrics.aappublications.org
- Ondansetron and the Risk of Cardiac Arrhythmias — www.annemergmed.com · www.annemergmed.com
- Evaluation and Management of Common Neonatal ... — neoreviews.aappublications.org · neoreviews.aappublications.org